Logotype for Upstream Bio Inc

Upstream Bio (UPB) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Upstream Bio Inc

Proxy filing summary

16 Apr, 2026

Executive summary

  • The annual meeting will be held virtually on June 9, 2026, with shareholders able to vote online or by proxy.

  • Shareholders will vote on electing two class II directors and ratifying the appointment of PwC as the independent auditor for 2026.

  • The company uses online proxy materials to reduce costs and environmental impact.

  • Only common stockholders as of April 13, 2026, are entitled to vote; each share equals one vote.

Voting matters and shareholder proposals

  • Proposal 1: Elect two class II directors (H. Edward Fleming, Jr., M.D. and Liam Ratcliffe, M.B.Ch.B., Ph.D.) for three-year terms expiring in 2029.

  • Proposal 2: Ratify PwC as independent registered public accounting firm for fiscal year ending December 31, 2026.

  • Shareholders may submit proposals for the 2027 meeting by December 17, 2026, or nominate directors with advance notice.

Board of directors and corporate governance

  • The board is divided into three classes with staggered three-year terms; currently seven members.

  • All directors except the CEO are considered independent under Nasdaq and SEC rules.

  • Board committees include audit, compensation, and nominating/governance, each with defined charters and responsibilities.

  • The chairperson and CEO roles are separated to enhance governance.

  • Directors are expected to attend at least 75% of meetings and the annual meeting.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more